About the Company
nanostring technologies (nasdaq: nstg) is a publicly held provider of life science tools for translational research and molecular diagnostics. the company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications. nanostring technologies provides life science tools for translational research and molecular diagnostic products. the company's ncounter® analysis system, which has been employed in basic and translational research since it was first introduced in 2008 and cited in more than 300 peer-reviewed publications, has also now been applied to diagnostic use as the ncounter dx analysis system. the company's technology offers a cost-effective way to easily profile the expression of hundreds of genes, mirnas, or copy number variations, simultaneously with high sensitivity and precision. the company's technology enables a wide variety of basic research and translational medicine applications, including biomarker discovery and vali
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $NSTG News
Bruker to Acquire the NanoString Business in an Asset Deal
Bruker Corporation (Nasdaq: BRKR) today announced that it has entered into a definitive acquisition agreement with NanoString ...
Bruker Gains On Nanostring Deal
Albertson Companies Flat on Financials <li /> GE Health Care Flies on Hookup with Elekta <li /> Centessa Gains on New Product ...
NanoString Technologies to Be Acquired by Bruker Corporation
NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and ...
Bruker unties Nanostring bankruptcy knot with $393M winning bid
Bruker Corp. shows no sign of slowing its buying binge, picking up Nanostring Technologies Inc. for $392.6 million in cash ...
Bruker will acquire biotech company- NanoString Technologies for ~$393M
Bruker ( NASDAQ: BRKR) will buy NanoString Technologies, a Seattle-based innovator in gene expression profiling and spatial ...
NanoString Technologies Inc NSTGQ
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
NanoString bankruptcy illustrates how patent disputes have become a biotech battleground
NanoString Technologies Inc.’s fortunes have tumbled during a series of legal challenges brought by competitor 10x Genomics Inc. After going through multiple rounds of layoffs in recent months ...
Bruker brokers $392M deal for frayed NanoString
Bruker Corporation has emerged as the winner of an auction for NanoString Technologies and its spatial biology assets after the company filed for Chapter 11 bankruptcy earlier this year. | Bruker has ...
Bruker to buy Seattle device maker in $393M deal
Seattle-based NanoString says its business will no longer be subject to bankruptcy proceedings once the deal closes.
Bruker to Acquire NanoString with $392.6M Winning Bid
NanoString Technologies has found a buyer in Bruker, which will acquire substantially all the bankrupt company’s assets for approximately $392.6 million cash, plus assumption of liabilities, after ...
NanoString Technologies Inc NSTGQ
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Loading the latest forecasts...